a total of 66 patients with advanced renal cell cancer received a combination of recombinant interferon alpha-2a ( 18 times 10 ( 6 ) units subcutaneously 3 times weekly ) and vinblastine ( 0.1 mg. per kg . intravenously every 3 weeks ) .
C0007134
renal cell cancer
C0021734
recombinant interferon alpha-2a